Amalgamated Bank’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9K | Hold |
1,887
| – | – | ﹤0.01% | 2509 |
|
|
2025
Q1 | $9K | Hold |
1,887
| – | – | ﹤0.01% | 2446 |
|
|
2024
Q4 | $9K | Hold |
1,887
| – | – | ﹤0.01% | 2512 |
|
|
2024
Q3 | $9K | Hold |
1,887
| – | – | ﹤0.01% | 2526 |
|
|
2024
Q2 | $11K | Hold |
1,887
| – | – | ﹤0.01% | 2410 |
|
|
2024
Q1 | $8K | Sell |
1,887
-3,023
| -62% | -$12.8K | ﹤0.01% | 2546 |
|
|
2023
Q4 | $21K | Sell |
4,910
-561
| -10% | -$2.4K | ﹤0.01% | 2634 |
|
|
2023
Q3 | $24K | Sell |
5,471
-17,451
| -76% | -$76.6K | ﹤0.01% | 2567 |
|
|
2023
Q2 | $151K | Sell |
22,922
-638
| -3% | -$4.2K | ﹤0.01% | 1923 |
|
|
2023
Q1 | $160K | Sell |
23,560
-1,782
| -7% | -$12.1K | ﹤0.01% | 1885 |
|
|
2022
Q4 | $187K | Hold |
25,342
| – | – | ﹤0.01% | 1888 |
|
|
2022
Q3 | $250K | Buy |
25,342
+126
| +0.5% | +$1.24K | ﹤0.01% | 1774 |
|
|
2022
Q2 | $275K | Buy |
25,216
+520
| +2% | +$5.67K | ﹤0.01% | 1736 |
|
|
2022
Q1 | $279K | Sell |
24,696
-1,475
| -6% | -$16.7K | ﹤0.01% | 1802 |
|
|
2021
Q4 | $411K | Sell |
26,171
-509
| -2% | -$7.99K | ﹤0.01% | 1669 |
|
|
2021
Q3 | $457K | Sell |
26,680
-422
| -2% | -$7.23K | ﹤0.01% | 1629 |
|
|
2021
Q2 | $583K | Buy |
+27,102
| New | +$583K | ﹤0.01% | 1550 |
|
|
2020
Q1 | – | Sell |
-10,084
| Closed | -$165K | – | 1782 |
|
|
2019
Q4 | $165K | Buy |
+10,084
| New | +$165K | ﹤0.01% | 1680 |
|
|
2019
Q1 | – | Sell |
-8,207
| Closed | -$214K | – | 1702 |
|
|
2018
Q4 | $214K | Buy |
+8,207
| New | +$214K | 0.01% | 1372 |
|